Tevogen Bio Holdings Inc. (TVGNW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$0.06

From 52W high−21.96%

Volume431086.00

Market cap$9.82M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$0.06

From 52W high

−21.96%

Volume

431086.00

Market cap

$9.82M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.7x

P/E (TTM)

—

RSI (14)

55.6

MomentumView details →

1D Return

−8.91%

YTD Return

+30.33%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.7x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−1.1x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

243.15%

ROA (TTM)

−457.14%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+36.07%

FCF YoY

+12.85%

Revenue CAGR 3Y

—

EPS CAGR 3Y

−72.65%

EBITDA YoY

+31.99%

MomentumView details →

1D Return

−8.91%

YTD Return

+30.33%

1Y Return

−6.30%

RSI (14)

55.6

vs 50D SMA

+7.15%

vs 200D SMA

+25.35%

Capital & dividendView details →

Debt/Equity

−0.34x

Current Ratio

0.33x

Quick Ratio

0.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.52

EPS Surprise

40.04%

Beats (12Q)

4/12

Next Q EPS Est

−$2.56

Avg Surprise (4Q)

32.75%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−21.61M

Op. CF (TTM)

−11.57M

Next earningsNov 24, 2026 →

Latest newsMore news →

Tevogen Inc. granted CEO and board chair Ryan Saadi 8,000,000 restricted shares and CFO Kirti Desai 750,000 restricted shares, effective September 14, 2026.4d ago

Tevogen Inc. elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors, effective August 24, 2026.26d ago

Similar companies

Senti Biosciences, Inc.SNTI Immuron LimitedIMRN FibroBiologics, Inc. Common StockFBLG Brainstorm Cell Therapeutics Inc.BCLI Aprea Therapeutics, Inc.APRE enGene Holdings Inc. WarrantsENGNW Find similar companies →

Latest newsMore news →

Tevogen Inc. granted CEO and board chair Ryan Saadi 8,000,000 restricted shares and CFO Kirti Desai 750,000 restricted shares, effective September 14, 2026.4d ago Tevogen Inc. elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors, effective August 24, 2026.26d ago Tevogen Bio Holdings Inc. announced it will operate under the name Tevogen Inc. following board approval.53d ago